期刊文献+

bcl-2蛋白在食管鳞状细胞癌及癌旁组织中的表达及其意义 被引量:2

Expression and significance of bcl-2 protein in esophageal squamous cell cancer and the surroundingtissues
原文传递
导出
摘要 目的 研究凋亡相关基因bcl-2在食管鳞癌及癌旁组织中的表达及意义。方法 应用Envision二步法检测62例食管鳞癌及癌旁组织中bcl-2蛋白的表达。结果 bcl-2在单纯增生、高级别上皮内瘤变及鳞癌组织中表达率分别为80.3 %,45.9%及67.7%,而正常食管黏膜组织中未见表达。正常粘膜组与其余各组之间有显著性差异(P﹤0.05);bcl-2蛋白表达与食管鳞癌的病理分级、浸润深度无相关性( P﹥0.05),但bcl-2蛋白的表达与淋巴结转移有相关性(P﹤0.05)。结论 bcl-2可能在食管癌早期阶段发挥作用,可能成为判断食管鳞癌预后的指标之一。 Objective To study the expression and significance of bcl-2 protein in esophageal squamous cell cancer and the surrounding tissues. Methods Envision method was used to analyze the expression of bcl-2 protein in 62 esophageal squamous cell cancer and the surrounding tissues. Results Expressions of bcl-2 protein were 80.3%,45.9%,45.9% and 67.7% in simple hyperplasia, high grade intraepithelial neoplasia and squamous cell carcinoma tissues respectively, but none in normal mucosa tissue. There were significant differences between normal esophageal mucosa and other groups ( P﹤0. 01) ; The expression of bcl-2 had no differentiation in grade of carcinoma、invasion( P﹥0. 05) .But it had significant relationship in the expression of bcl-2 and lymph node metastasis(P﹤0.05). Conclusion bcl-2 plays the roles in the different stage of occurrence of esophageal squamous cell cancer, bcl-2 may predicting the occurrence of esophageal squamous cell cancer in early stage, and may be regarded as an useful index for prognosis.
出处 《肿瘤研究与临床》 CAS 2012年第9期622-624,共3页 Cancer Research and Clinic
基金 山西省留学人员科研项目(105)
关键词 食管肿瘤 肿瘤 鳞状细胞 免疫组织化学 BCL-2 Esophageal neoplasms Neoplasms, squamous cell Immunohistochemistry bcl-2
  • 相关文献

参考文献5

二级参考文献29

  • 1中华病理学杂志编辑委员会.《全国免疫组织化学技术与诊断标准化专题研讨会》会议纪要[J].中华病理学杂志,1996,25(6):326-328.
  • 2Shivapurkar N,Reddy J,Chaudhary PM,et al.Apoptosis and lung cancer:a review.J Cell Biochem,2003,88:885-898.
  • 3Paik KH,Park YH,Ryoo BY,et al.Prognostic value of immunohistochemical staining of p53,bcl-2,and Ki-67 in small cell lung cancer.J Korean Med Sci,2006,21:35-39.
  • 4Tsujimoto Y,Gorham J,Cossman J,et al.The t (14;18)chromosome transloeations involved in B-cell neoplasms result from mistakes in VDJ joining.Science,1985,229:1390-1393.
  • 5Tamm I,Dorken B,Hartmann G.Antisense therapy in oncology:New hope for an old idea? Lancet,2001,358:489-497.
  • 6Hann CL,Daniel VC,Sugar EA,et al.Therapeutic efficacy of ABT737,a selective inhibitor of BCL-2 in small cell lung cancer.Cancer Res,2008,68:2321-2328.
  • 7Rudin CM,Otterson GA,Mauer AM,et al.A pilot trial of G3139,a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer.Ann Oncol,2002,13:539-545.
  • 8Rudin CM,Kozloff M,Hoffman PC,et al.Phase I study of G3139,a bcl-2 antisense oligonucleotide,combined with carboplatin and etoposide in patients with small cell lung cancer.J Clin Oncol,2004,22:1110-1117.
  • 9Rudin CM,Salgia R,Wang X,et al.Randomized phase Ⅱ study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:CALGB30103.J ClAin Oncol,2008,26:870-876.
  • 10Marcucci G,Stock W,Dai G,et al.Phase Ⅰ study of oblimersen sodium,an antisense to Bcl-2,in untreated older patients with acute myeloid leukemia:pharmacokinetics,pharmacodynemics,and clinical activity.J Clin Oncol,2005,23:3404-3411.

共引文献65

同被引文献18

  • 1Condorelli G, Vigliotta G, lavarnne C, et aI.PED/PEA-15 gene cnntrols glucose transport and is over-expressed in type-diabetes mellitus. EMBO J, 1998, 17: 3858-3866.
  • 2Gaumont-Leclere MF, Mukhopadhyay UK, Goumard S, et al. PEA-15 is inhibited by adennvirus EIA mid plays a role in ERK nuclear export and Has-induced senescence. J Biol Chem, 2004, 279: 46802-46809.
  • 3Whitehurst AW, Robinson FL, M re MS, et al. The death effeelor domain protein PEA-15 prevents nuclear entry of ERK2 by inhibitingrequiredinteraetions. J BinlChem. 2004, 279: 12840- 128407.
  • 4Hao C, Beg uinot F, Condorelli C, et al. Induction and intraeellular regulatinn of tumor neerosis faetor-relaled apoptosis-indueing ligand (TRAIL) mediated apolnsis in human malignant glioma cells. Cancer Res, 2001,61:1162-1170.
  • 5McEleny KR, Watson RW, Cnffey RN, el al.lnhibitors ofapoptosis proteins in prostate eaneer cell lines. Prnstate, 2002, 51: 133-140.
  • 6Jo M, Kim TH, Seol DW, el M. Apoplnsis induced innormai human hepatocyles by tumor necrosis factnr-relaled apnptosis-indacing ligand. Nat Med, 2000, 6: 564-567.
  • 7Stassi G, Garcffalo M, Zerilli M, el a]. PED mediales AKT-dependent ehemoresistanee in human breast cancer ceils. Cancer Res, 2005, 65: 6668-6675.
  • 8Panariello F, Perruoln G, Cassese A, el al. Clozapine impai insulin aelion by up-regulaling Akt phosphorylatinn and Ped/Pea-15 protein abundance. J Cell Physinl, 2012, 227:1485-1492.
  • 9Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogene- sis and prevention [ J ]. Nat Clin Pract Gastroenterol Hepatol,2008,5 (9) :517-26.
  • 10Xiao LJ, Zhao S, Zhao EH, et al. Clinicopathologieal and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carci- nomas[ J]. Oncol Lett,2013,6(5 ) :1277-1284.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部